Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01576536 · ClinicalTrials.gov registry record
Genetic Variation in Platelet Aggregation
A clinical trial of Myocardial Infarction, sponsored by Vanderbilt University.
- Completed
- Registry status
- 117
- Enrollment target
- 1
- Study location
NCT01576536 is a study of Myocardial Infarction that has completed, run by Vanderbilt University. The registered enrollment target is 117 participants, below the 4,680-participant average among 64 other Myocardial Infarction trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state.
The verdict
NCT01576536, a study of Myocardial Infarction, has completed, sponsored by Vanderbilt University.
- COMPLETED
- Registry status
- 117 participants
- Enrollment target
- 1
- Study location
Study Summary
The aim of the study is to test whether genetic variation in the alpha 2A adrenergic receptor affects diurnal variation in platelet aggregation.
Conditions Studied
Study Locations (1)
Tennessee
- the Vanderbilt University General Clinical Research Center - Nashville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 117 participants |
| Start Date | 2012-07 |
| Est. Completion | 2016-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01576536
The ClinicalTrials.gov registry entry for NCT01576536 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 117 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 4,680-participant average among 64 other Myocardial Infarction trials with a reported enrollment target (97% lower). The listed sponsor is Vanderbilt University, which has 430 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Myocardial Infarction appearing as the primary indexed condition, and to 0 interventions.
NCT01576536 reports 1 study location spanning 1 distinct geographic area - top geographies include Tennessee.
Frequently Asked Questions
What is clinical trial NCT01576536 about?
NCT01576536 is a clinical study titled "Genetic Variation in Platelet Aggregation". The aim of the study is to test whether genetic variation in the alpha 2A adrenergic receptor affects diurnal variation in platelet aggregation.
What is the current status of trial NCT01576536?
This trial is currently completed. The enrollment target is 117 participants. The study started on 2012-07. Estimated completion is 2016-12.
What conditions does trial NCT01576536 study?
This clinical trial studies the following conditions: Myocardial Infarction.
Who is sponsoring clinical trial NCT01576536?
This trial is sponsored by Vanderbilt University, which has 430 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01576536 being conducted?
This trial has 1 study location across Tennessee. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Myocardial Infarction
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Integration of Telemedicine and Home-Based Cardiac Rehabilitation: Feasibility, Efficacy, and Adherence
RECRUITING
-
MCNAIR Study: coMparative effeCtiveness of iN-person and teleheAlth cardIac Rehabilitation
RECRUITING · NA
-
Women's Heart Attack Research Program: Stress Ancillary Study
RECRUITING · NA
-
AI-Enabled Direct-from-ECG Ejection Fraction (EF) Severity Assessment Using COR ECG Wearable Monitor
RECRUITING
-
Heart Attack Research Program: Platelet Sub-Study (HARP)
RECRUITING
-
Circulating Markers for Ischemic Heart Disease
RECRUITING
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.